New patents issued for core rare disease target indications for crofelemer
Napo has approximately 200 patents issued and pending
Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (MVID), an ultrarare CDD, in the US, EU, and Middle East/North Africa regions, with results expected in 2024 and 2025
Read MoreDuane Boise, President of MMJ BioPharma Cultivation, stated, "I think most Americans want judges who don't mind telling the truth and don't mind saying we're wrong. Unlike the DEA's arrogant attitude of, if we make a mistake, we won't be called on it, however MMJ is doing exactly that. The most immature thing you can do is say, 'no, no, I didn't make a mistake.' The mature thing to do, that all adults learn to do in this country is to say, 'oops, that was a mistake. I'm going to fix it. I'm sorry.'"
Read More
Duane Boise President of MMJ companies applauded the supreme court ruling saying "after years of DEA gross misconduct and blatant misinterpretation of marijuana research and development policy the Constitution still matters. Now the DEA will have to clean up their in-house kangaroo court system to allow a fair and impartial administrative law hearing".
Read MoreReceived reimbursement from insurance payors for the first time in Company history during first quarter, which is expected to increase as a percentage of total revenue going forward
Following its IPO in early June, the Company has sufficient capital to fund operations and execute on its growth strategy for at least the next 12 months
Read More
